| Announce Date | 01/28/2026 |
| EPS Normalized Actual | $0.96 (Beat by $0.31) |
| EPS GAAP Actual | $0.96 (Beat by $0.31) |
| Revenue Actual | $4.711B |
| Revenue Surprise | Beat by $4711M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.585 |
| EPS GAAP Estimate | $0.585 |
| Revenue Estimate | $3.9215B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 4.05 | 8.47 | 3.99236 | 4.14247 | 1 |
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.42 | -0.25577 | 4.711B | 10.23% | 649.93M |
| FQ3 2025 (Sep 2025) | 0.38 | -0.27625 | 4.48B | 3.3% | 367.56M |
| FQ2 2025 (Jun 2025) | 0.25 | -0.40623 | 4.176B | 0.29% | 63.56M |
| FQ1 2025 (Mar 2025) | 0.19 | -0.3876 | 3.891B | 1.85% | 28.28M |
| FQ4 2024 (Dec 2024) | -0.19 | -0.81708 | 4.229B | -5.39% | 220.2M |
| FQ3 2024 (Sep 2024) | -0.39 | -0.97268 | 4.332B | 11.13% | 331.83M |
| FQ2 2024 (Jun 2024) | -0.75 | -2.09259 | 4.164B | 6.87% | -3592M |
| FQ1 2024 (Mar 2024) | -0.12 | -0.12 | 3.819B | 4.14% | 3819M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.585
Consensus Revenue Estimates
3.9215B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.79 | 46.84 | 0.77536 | 0.82069 | 1 |
| FQ3 2026 (Sep 2026) | 0.74 | 48.65 | 0.71907 | 0.76093 | 1 |
| FQ2 2026 (Jun 2026) | 0.66 | 62.12 | 0.64134 | 0.67867 | 1 |
| FQ1 2026 (Mar 2026) | 0.585 | 67.52 | 0.56094 | 0.60618 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 4.41B | -6.79 | 4.35B | 4.54B | 3 |
| FQ3 2026 (Sep 2026) | 4.27B | -5.03 | 4.17B | 4.36B | 2 |
| FQ2 2026 (Jun 2026) | 4.11B | -1.71 | 4.02B | 4.2B | 2 |
| FQ1 2026 (Mar 2026) | 3.92B | 0.78 | 3.8B | 4.03B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.67577 | 0.42 | -0.25577 | -60.9% |
| FQ3 2025 (Sep 2025) | 0.65625 | 0.38 | -0.27625 | -72.7% |
| FQ2 2025 (Jun 2025) | 0.65623 | 0.25 | -0.40623 | -162.49% |
| FQ1 2025 (Mar 2025) | 0.5776 | 0.19 | -0.3876 | -204% |
| FQ4 2024 (Dec 2024) | 0.62708 | -0.19 | -0.81708 | 430.04% |
| FQ3 2024 (Sep 2024) | 0.58268 | -0.39 | -0.97268 | 249.41% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.75 | -2.09259 | 279.01% |
| FQ1 2024 (Mar 2024) | -0.12 | -0.12 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $4.06B | $4.71B | $649.93M | 13.8% |
| FQ3 2025 (Sep 2025) | $4.11B | $4.48B | $367.56M | 8.2% |
| FQ2 2025 (Jun 2025) | $4.11B | $4.18B | $63.56M | 1.52% |
| FQ1 2025 (Mar 2025) | $3.86B | $3.89B | $28.28M | 0.73% |
| FQ4 2024 (Dec 2024) | $4.01B | $4.23B | $220.2M | 5.21% |
| FQ3 2024 (Sep 2024) | $4B | $4.33B | $331.83M | 7.66% |
| FQ2 2024 (Jun 2024) | $7.76B | $4.16B | $-3592M | -86.26% |
| FQ1 2024 (Mar 2024) | $0B | $3.82B | $3819M | 100% |